References
- Molloy RG, Mannick JA, Rodrick ML. Cytokines, sepsis and immunomodulation. Br J Surg 1993;80:289–297.
- Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008;8:958–969.
- Sun Y, Liu WZ, Liu T, et al. Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res 2015;35:600–604.
- Carter AB, Knudtson KL, Monick MM, et al. The p38 mitogen-activated protein kinase is required for NF-kappaB-dependent gene expression. The role of TATA-binding protein (TBP). J Biol Chem 1999;274:30858–30863.
- Ben-Neriah Y. Regulatory functions of ubiquitination in the immune system. Nature Immunology 2002;3:20–26.
- Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 2000;18:621–663.
- Dengler V, Downey GP, Tuder RM, et al. Neutrophil intercellular communication in acute lung injury emerging roles of microparticles and gap junctions. Am J Respir Cell Mol Biol 2013;49:1–5.
- Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest 2012;122:2731–2740.
- Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005;353:1685–1693.
- Zhang X, Song K, Xiong H, et al. Protective effect of florfenicol on acute lung injury induced by lipopolysaccharide in mice. Int Immunopharmacol 2009;9:1525–1529.
- Singh N. Acute lung injury and acute respiratory distress syndrome. Lancet 2007;370:383–384.
- Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 2007;369:1553–1564.
- Xie KL, Yu YH, Huang Y, et al. Molecular hydrogen ameliorates lipopolysaccharide-induced acute lung injury in mice through reducing inflammation and apoptosis. Shock 2012;37:548–555.
- Chen T, Mou Y, Tan JN, et al. The protective effect of CDDO-Me on lipopolysaccharide-induced acute lung injury in mice. Int Immunopharmacol 2015;25:55–64.
- Grommes J, Soehnlein O. Contribution of neutrophils to acute lung injury. Mol Med 2011;17:293–307.
- Chopra M, Reuben JS, Sharma AC. Acute Lung injury:apoptosis and signaling mechanisms. Exp Biol Med (Maywood) 2009;234:361–371.
- Goodman RB, Pugin J, Lee JS, et al. Cytokine-mediated inflammation in acute lung injury. Cytokine. Cytokine Growth Factor Rev 2003;14:523–535.
- Togbe D, Schnyder-Candrian S, Schnyder B, et al. Toll-like receptor and tumour necrosis factor dependent endotoxin-induced acute lung injury. Int J Exp Pathol 2007;88:387–391.
- Bhatia M, Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 2004;202:145–156.
- Pawliczak R, Han C, Huang XL, et al. 85-kDa cytosolic phospholipase A2 mediates peroxisome proliferator-activated receptor gamma activation in human lung epithelial cells. J Biol Chem 2002;277:33153–33163.
- Suratt BT, Parsons PE. Mechanisms of acute lung injury/acute respiratory distress syndrome. Clin Chest Med 2006;27:579–589.
- Welbourn CR, Young Y. Endotoxin, septic shock and acute lung injury: neutrophils, macrophages and inflammatory mediators. Br J Surg 1992;79:998–1003.
- Chen WN, Xu LZ, Feng XX, et al. The antiinflammatory and immunologic effect of anthraquinone of Rubia Cordifolia L. J Weifang Med Coll 2002;24:8–10.
- Wang CA, Zhou Y, Zhang DQ, et al. The antitumor efficacy of CM36. CHN J Immunol 1995;11:109.
- Yang LR, Zhou QH, Zhang ZF, et al. Chemical composition and pharmacological activity research progress of Rubia cordifolia L. CHN Med Infor 2007;24:21–23.
- Zhang WC, Zheng XJ, Du LJ, et al. High salt primes a specific activation state of macrophages, M(Na). Cell Res 2015;25:893–910.
- Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 2001;13:85–94.
- Hong S, Kim SH, Rhee MH, et al. In vitro anti-inflammatory and pro-aggregative effects of a lipid compound, petrocortyne A, from marine sponges. Naunyn Schmiedebergs Arch Pharmacol 2003;368:448–456.
- Arthur JS, Ley SC. Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol 2013;13:679–692.
- Karin M, Delhase M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin Immunol 2000;12:85–98.
- Libermann TA, Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 1990;10:2327–2334.
- Martinon F. Signaling by ROS drives inflammasome activation. Europ J Immunol 2010;40:616–619.
- Uto T, Fujii M, Hou DX. 6-(Methylsulfinyl)hexyl isothiocyanate suppresses inducible nitric oxide synthase expression through the inhibition of Janus kinase 2-mediated JNK pathway in lipopolysaccharide-activated murine macrophages. Biochem Pharmacol 2005;70:1211–1221.
- Kim SJ, Kim MC, Lee BJ, et al. Anti-Inflammatory Activity of Chrysophanol through the Suppression of NF-kappaB/caspase-1 activation in vitro and in vivo. Molecules 2010;15:6436–6451.
- Yu C, Qi D, Sun JF, et al. Rhein prevents endotoxin-induced acute kidney injury by inhibiting NF-kappa B activities. Sci Rep 2015;5:1–16.
- Joh EH, Gu W, Kim DH. Echinocystic acid ameliorates lung inflammation in mice and alveolar macrophages by inhibiting the binding of LPS to TLR4 in NF-κB and MAPK pathways . Biochem Pharmacol 2012;84:331–340.
- Wu J, Zhang YY, Guo L, et al. Bupleurum Polysaccharides Attenuates Lipopolysaccharide-Induced Inflammation via Modulating Toll-Like Receptor 4 Signaling. PLoS One 2013;8:e78051. doi: 10.1371/journal.pone.0078051